Chinese pharma services firm WuXi AppTec launches 6.78b yuan convertible bond

Chinese pharmaceutical services company WuXi AppTec (2359) has launched a 6.78 billion yuan (HK$7.82 billion) zero-coupon convertible bond offering due in 2027, according to a term sheet seen by Reuters on Thursday.

The bonds mature in May 2027. Investors can convert them into WuXi AppTec's Hong Kong-listed shares. The bonds are denominated in yuan, linked to offshore yuan and settled in US dollars, the sheet shows.

WuXi AppTec will use the proceeds for global expansion and general corporate purposes, according to the sheet.

The company is offering the bonds at 103.0 percent to 103.5 percent of face value. That gives a yield to maturity of minus 3.5 percent to minus 3.0 percent a year.

The conversion price will be set at a 20 percent premium to the reference Hong Kong share price. Pricing is expected on or around May 14, according to the sheet.

WuXi AppTec did not immediately respond to an email seeking comment on Thursday.

Reuters

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗧𝗵𝗲 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱 𝗔𝗽𝗽 ↓